+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Equine Pharmaceuticals & Supplements Market - Global Forecast 2026-2032- Product Image
Equine Pharmaceuticals & Supplements Market - Global Forecast 2026-2032- Product Image
Sale

Equine Pharmaceuticals & Supplements Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989692
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Equine Pharmaceuticals & Supplements Market is projected to reach USD 1.08 Billion in 2026. It is expected to continue growing at a CAGR of 6.08%, reaching USD 1.56 Billion by 2032.

The equine pharmaceuticals and supplements market is being reshaped by rising expectations for horse health, athletic performance, welfare, and compliant medication use across racing, sport, breeding, leisure, and working-horse populations. Demand spans anti-infectives, anti-inflammatory drugs, parasiticides, vaccines, reproductive therapies, dermatology products, digestive support, joint health supplements, electrolytes, calming formulations, and nutrition-based performance support.

For manufacturers, growth momentum is strongest where products combine clinical credibility, label transparency, residue-risk awareness, and convenient administration. Veterinarian recommendation remains central for prescription equine medicine, while supplement brands compete on ingredient quality, palatability, third-party testing, and evidence-based claims that align with animal health regulations and competition rules.

Transformative Shifts in the Equine Health Landscape

The landscape is shifting from reactive treatment toward preventive equine healthcare, with owners investing earlier in vaccination, parasite control, mobility support, gastric health, and nutritional supplementation. This shift is supported by longer athletic careers for performance horses, rising companion-horse ownership, and stronger welfare expectations across professional and recreational segments.

Regulatory scrutiny is also transforming product strategy. Authorities such as the FDA Center for Veterinary Medicine, the European Medicines Agency, and national veterinary regulators continue to emphasize drug safety, antimicrobial stewardship, pharmacovigilance, and truthful labeling. For supplement manufacturers, this increases the value of documented sourcing, validated quality systems, and claims that avoid crossing into unapproved drug territory.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence equine pharmaceuticals and supplements through faster signal detection, predictive inventory planning, formulation screening, and field-level pharmacovigilance. AI-enabled analysis of veterinary records, adverse event reports, lab results, and wearable data can help identify emerging safety patterns and support more responsive product lifecycle management.

The cumulative impact is especially relevant in precision nutrition and performance management. Algorithms can combine body condition, workload, age, breed, diet, climate, and recovery data to guide supplement recommendations, while computer vision and imaging analytics can support lameness assessment. The strongest commercial value will come from AI systems that remain transparent, veterinarian-supervised, and compliant with data privacy, animal welfare, and medical device expectations.

Key Regional Insights

North America remains a high-value region due to established equine veterinary infrastructure, large sport and leisure horse populations, and strong spending on companion-animal style care. The United States is particularly important for branded equine pharmaceuticals, specialty supplements, and performance-horse health programs, while Canada benefits from organized equestrian sport, breeding activity, and veterinary-led care.

Europe is shaped by strict veterinary medicine regulation, competition medication rules, and welfare-driven purchasing across racing, sport, and leisure segments. The European Medicines Agency framework and national authorities reinforce pharmacovigilance, responsible antimicrobial use, and compliant claims, making quality documentation critical for suppliers. Asia-Pacific is expanding as China, India, Japan, Australia, and South Korea invest in racing, breeding, leisure riding, and premium animal health services. Latin America, led by Brazil and Mexico, shows demand in racing, polo, rodeo, ranching, and working-horse health. The Middle East is influenced by endurance racing, Arabian horse breeding, and elite equine facilities, while Africa combines premium sport-horse demand with essential access needs for working equids supported by welfare and veterinary outreach programs.

Key Group Insights

ASEAN markets are gaining relevance as equestrian clubs, racing venues, and veterinary services expand in countries with rising disposable income and growing interest in leisure riding. The GCC is a premium opportunity for equine supplements, joint support, electrolytes, gastric support, and recovery products because high-value Arabian horses and endurance disciplines require disciplined health management in hot climates.

The European Union is a benchmark for regulatory compliance under modern veterinary medicinal product rules, including tighter controls on antimicrobial use and clearer expectations for pharmacovigilance. BRICS countries combine large animal populations with uneven but improving access to equine healthcare, creating demand for both essential medicines and premium performance products. G7 markets are mature, brand-sensitive, and evidence-driven, with high expectations for validated quality, traceability, and veterinarian endorsement. NATO-aligned markets generally show strong biosecurity awareness, structured veterinary services, and demand for reliable supply chains that can support consistent access to equine pharmaceuticals and supplements.

Key Country Insights

The United States leads demand through racing, sport horse, breeding, and recreational ownership, with veterinarians influencing prescription therapies and high-trust supplement adoption. Canada, Mexico, and Brazil support demand through racing, ranching, rodeo, sport, and working-horse health, with opportunities for parasite control, anti-inflammatory therapy, vaccination, electrolyte support, and musculoskeletal supplements. The United Kingdom, Germany, France, Italy, and Spain remain important European markets due to equestrian sport, breeding programs, racing traditions, and mature veterinary services, while Russia presents demand shaped by regional access, regulatory complexity, and distribution constraints.

China and India offer long-term potential as equine sport, leisure riding, and organized veterinary care develop alongside traditional working-horse use and breeding activities. Japan, Australia, and South Korea are advanced Asia-Pacific markets with strong racing ecosystems, high welfare expectations, structured veterinary oversight, and premium product adoption. Across these countries, success depends on local regulatory classification, veterinarian engagement, channel reliability, competition-rule awareness, residue-risk management, and documented product quality.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize veterinary credibility by investing in controlled studies, transparent ingredient documentation, stability testing, residue-risk assessment, and post-market safety monitoring. Brands that substantiate claims without overstating drug-like effects can build stronger trust with veterinarians, trainers, owners, breeders, and regulators.

Manufacturers should also diversify supply chains for active pharmaceutical ingredients, botanicals, minerals, and specialty nutrients while maintaining audit-ready quality systems. Digital education, competition-compliant labeling, palatable formats, and climate-appropriate products such as electrolytes, hydration support, and recovery formulations can improve adoption in both mature and emerging equine markets.

Research Methodology

This executive summary is based on a structured review of verified public sources, including veterinary regulatory frameworks, animal health guidance, equestrian sport medication rules, official livestock and horse population references, and published veterinary literature. The analysis emphasizes observable demand drivers and regulatory developments rather than unsupported market-size estimates.

The methodology integrates product-category mapping, regional adoption patterns, regulatory review, and stakeholder assessment across veterinarians, manufacturers, distributors, trainers, breeders, and horse owners. Insights were validated through triangulation of regulatory direction, equine healthcare practices, competition requirements, welfare standards, and documented trends in preventive animal health, precision nutrition, and performance management.

Conclusion

The equine pharmaceuticals and supplements market is moving toward evidence-led, welfare-centered, and digitally supported care. Preventive medicine, precision nutrition, antimicrobial stewardship, and competition-compliant performance support are defining product development and brand positioning.

Manufacturers that combine scientific validation, transparent labeling, reliable supply, and veterinarian engagement will be best positioned to strengthen trust and expand adoption. As AI, wearable monitoring, and data-driven nutrition become more practical, the market will reward companies that improve equine health outcomes while maintaining regulatory discipline, medication compliance, and owner confidence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Equine Pharmaceuticals & Supplements Market, by Product Type
7.1. Introduction
7.2. Pharmaceuticals
7.3. Supplements
8. Equine Pharmaceuticals & Supplements Market, by Therapeutic Category
8.1. Introduction
8.2. Anesthetic Agents
8.3. Anti-Infectives
8.3.1. Aminoglycosides
8.3.2. Macrolides
8.3.3. Penicillins
8.3.4. Sulfonamides
8.3.5. Tetracyclines
8.4. Anti-Inflammatories
8.4.1. Corticosteroids
8.4.2. NSAIDs
8.5. Cardiovascular Agents
8.6. Gastrointestinal Agents
8.7. Hormonal Preparations
8.8. Nervous System Agents
8.9. Vaccines
9. Equine Pharmaceuticals & Supplements Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Intravenous
9.2.3. Subcutaneous
9.3. Oral
9.3.1. Powders
9.3.2. Syrups
9.3.3. Tablets
9.4. Topical
10. Equine Pharmaceuticals & Supplements Market, by Formulation
10.1. Introduction
10.2. Creams
10.3. Emulsions
10.4. Gels
10.5. Powders
10.6. Solutions
10.7. Tablets
11. Equine Pharmaceuticals & Supplements Market, by End User
11.1. Introduction
11.2. Equine Farms
11.3. Research Institutions & Academics
11.4. Veterinary Clinics & Ambulatory Services
11.5. Veterinary Hospitals
12. Equine Pharmaceuticals & Supplements Market, by Distribution Channel
12.1. Introduction
12.2. Online Pharmacies
12.3. Retail Pharmacies
12.4. Veterinary Hospitals & Clinics
12.5. Veterinary Pharmacies
13. Equine Pharmaceuticals & Supplements Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Equine Pharmaceuticals & Supplements Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Equine Pharmaceuticals & Supplements Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Aurora Pharmaceutical, Inc.
17.2. Biogenesis Bago
17.3. Biovac Ltd.
17.4. Boehringer Ingelheim GmbH
17.5. Ceva Santé Animale
17.6. Chanelle Pharma
17.7. China Animal Husbandary
17.8. Dechra Pharmaceuticals PLC
17.9. ECO - Animal Health Ltd.
17.10. Elanco Animal Health Incorporated
17.11. Heska Corporation
17.12. Hester Biosciences Limited
17.13. Indian Immunologicals Ltd.
17.14. Intas Animal Health
17.15. Laboratorio Drag Pharma Chile Invetec S.A.
17.16. Merck Animal Health
17.17. Neogen Corporation
17.18. Norbrook Laboratories Limited
17.19. Phibro Animal Health
17.20. Teknofarma S.r.l.
17.21. Vetoquinol Group
17.22. Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
17.23. Virbac S.A.
17.24. Zendal group
17.25. Zoetis Inc.
18. Key Experts
List of Figures
FIGURE 1. Global Equine Pharmaceuticals & Supplements Market, Years Considered for the Study
FIGURE 2. Global Equine Pharmaceuticals & Supplements Market, Research Design
FIGURE 3. Global Equine Pharmaceuticals & Supplements Market, Research Framework
FIGURE 4. Global Equine Pharmaceuticals & Supplements Market, Data Triangulation
FIGURE 5. Global Equine Pharmaceuticals & Supplements Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2025 vs 2032 (%)
FIGURE 9. Global Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 13. Global Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Equine Pharmaceuticals & Supplements Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Equine Pharmaceuticals & Supplements Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Equine Pharmaceuticals & Supplements Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Equine Pharmaceuticals & Supplements Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Equine Pharmaceuticals & Supplements Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Equine Pharmaceuticals & Supplements Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Equine Pharmaceuticals & Supplements Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Equine Pharmaceuticals & Supplements Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Equine Pharmaceuticals & Supplements Market Segmentation & Coverage
TABLE 2. Global Equine Pharmaceuticals & Supplements Market Size, 2017-2032 (USD Million)
TABLE 3. Global Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Pharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Pharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Pharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 11. Global Anesthetic Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Anesthetic Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Anesthetic Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Anti-Infectives Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Anti-Infectives Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Anti-Infectives Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Aminoglycosides Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Aminoglycosides Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Aminoglycosides Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Macrolides Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Macrolides Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Macrolides Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Penicillins Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Penicillins Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Penicillins Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Sulfonamides Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Sulfonamides Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Sulfonamides Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Tetracyclines Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Tetracyclines Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Tetracyclines Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Anti-Inflammatories Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Anti-Inflammatories Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Anti-Inflammatories Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Corticosteroids Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Corticosteroids Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Corticosteroids Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global NSAIDs Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global NSAIDs Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global NSAIDs Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Cardiovascular Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Cardiovascular Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Cardiovascular Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Gastrointestinal Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Gastrointestinal Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Gastrointestinal Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Hormonal Preparations Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Hormonal Preparations Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Hormonal Preparations Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Nervous System Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Nervous System Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Nervous System Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 57. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Powders Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Powders Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Powders Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Syrups Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Syrups Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Syrups Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 85. Global Creams Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Creams Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Creams Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Emulsions Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Emulsions Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Emulsions Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Gels Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Gels Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Gels Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Powders Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Powders Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Powders Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Global Equine Farms Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Equine Farms Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Equine Farms Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Research Institutions & Academics Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Research Institutions & Academics Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Research Institutions & Academics Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Veterinary Clinics & Ambulatory Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Veterinary Clinics & Ambulatory Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Veterinary Clinics & Ambulatory Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Veterinary Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Veterinary Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Veterinary Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Veterinary Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Veterinary Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Veterinary Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Equine Pharmaceuticals & Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Equine Pharmaceuticals & Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. North America Equine Pharmaceuticals & Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. North America Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. North America Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 144. North America Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 145. North America Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 146. North America Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 147. North America Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 148. North America Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 149. North America Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 150. North America Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. North America Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. Latin America Equine Pharmaceuticals & Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Latin America Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. Latin America Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 155. Latin America Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 156. Latin America Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 157. Latin America Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 158. Latin America Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 159. Latin America Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 160. Latin America Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 161. Latin America Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. Latin America Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. Europe Equine Pharmaceuticals & Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Europe Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. Europe Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 166. Europe Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 167. Europe Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 168. Europe Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 169. Europe Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 170. Europe Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 171. Europe Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 172. Europe Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Europe Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 174. Middle East Equine Pharmaceuticals & Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. Middle East Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. Middle East Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 177. Middle East Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 178. Middle East Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 179. Middle East Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 180. Middle East Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 181. Middle East Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 182. Middle East Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 183. Middle East Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. Middle East Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 185. Africa Equine Pharmaceuticals & Supplements Market Size, by Region, 2017-2032 (USD Million)
TABLE 186. Africa Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 187. Africa Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 188. Africa Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 189. Africa Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 190. Africa Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 191. Africa Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 192. Africa Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 193. Africa Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 194. Africa Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Africa Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. Global Equine Pharmaceuticals & Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. ASEAN Equine Pharmaceuticals & Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. ASEAN Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. ASEAN Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 200. ASEAN Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 201. ASEAN Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 202. ASEAN Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 203. ASEAN Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 204. ASEAN Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 205. ASEAN Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 206. ASEAN Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. ASEAN Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. GCC Equine Pharmaceuticals & Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. GCC Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. GCC Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 211. GCC Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 212. GCC Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 213. GCC Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 214. GCC Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 215. GCC Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 216. GCC Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 217. GCC Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. GCC Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. European Union Equine Pharmaceuticals & Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 220. European Union Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 221. European Union Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 222. European Union Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 223. European Union Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 224. European Union Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 225. European Union Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 226. European Union Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 227. European Union Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 228. European Union Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. European Union Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. BRICS Equine Pharmaceuticals & Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 231. BRICS Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. BRICS Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 233. BRICS Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 234. BRICS Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 235. BRICS Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 236. BRICS Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 237. BRICS Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 238. BRICS Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 239. BRICS Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. BRICS Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 241. G7 Equine Pharmaceuticals & Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 242. G7 Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 243. G7 Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 244. G7 Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 245. G7 Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 246. G7 Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 247. G7 Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 248. G7 Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 249. G7 Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 250. G7 Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. G7 Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. NATO Equine Pharmaceuticals & Supplements Market Size, by Group, 2017-2032 (USD Million)
TABLE 253. NATO Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. NATO Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 255. NATO Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 256. NATO Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 257. NATO Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 258. NATO Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 259. NATO Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 260. NATO Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 261. NATO Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. NATO Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 263. Global Equine Pharmaceuticals & Supplements Market Size, by Country, 2017-2032 (USD Million)
TABLE 264. United States Equine Pharmaceuticals & Supplements Market Size, 2017-2032 (USD Million)
TABLE 265. United States Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 266. United States Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 267. United States Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 268. United States Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 269. United States Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 270. United States Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 271. United States Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 272. United States Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 273. United States Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. United States Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. Canada Equine Pharmaceuticals & Supplements Market Size, 2017-2032 (USD Million)
TABLE 276. Canada Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 277. Canada Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 278. Canada Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 279. Canada Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 280. Canada Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 281. Canada Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 282. Canada Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 283. Canada Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 284. Canada Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. Canada Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 286. Mexico Equine Pharmaceuticals & Supplements Market Size, 2017-2032 (USD Million)
TABLE 287. Mexico Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 288. Mexico Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 289. Mexico Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 290. Mexico Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 291. Mexico Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 292. Mexico Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 293. Mexico Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 294. Mexico Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 295. Mexico Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. Mexico Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 297. Brazil Equine Pharmaceuticals & Supplements Market Size, 2017-2032 (USD Million)
TABLE 298. Brazil Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 299. Brazil Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 300. Brazil Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 301. Brazil Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 302. Brazil Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 303. Brazil Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 304. Brazil Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 305. Brazil Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 306. Brazil Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 307. Brazil Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 308. United Kingdom Equine Pharmaceuticals & Supplements Market Size, 2017-2032 (USD Million)
TABLE 309. United Kingdom Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 310. United Kingdom Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 311. United Kingdom Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 312. United Kingdom Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 313. United Kingdom Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 314. United Kingdom Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 315. United Kingdom Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 316. United Kingdom Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 317. United Kingdom Equine Pharmaceuticals & Supplements Market Size, by End User, 2017-2032 (USD Million)
TABLE 318. United Kingdom Equine Pharmaceuticals & Supplements Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 319. Germany Equine Pharmaceuticals & Supplements Market Size, 2017-2032 (USD Million)
TABLE 320. Germany Equine Pharmaceuticals & Supplements Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 321. Germany Equine Pharmaceuticals & Supplements Market Size, by Therapeutic Category, 2017-2032 (USD Million)
TABLE 322. Germany Equine Pharmaceuticals & Supplements Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 323. Germany Equine Pharmaceuticals & Supplements Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 324. Germany Equine Pharmaceuticals & Supplements Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 325. Germany Equine Pharmaceuticals & Supplements Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 326. Germany Equine Pharmaceuticals & Supplements Market Size, by Oral, 2017-2032 (USD Million)
TABLE 327. Germany Equine Pharmaceuticals & Supplements Market Size, by Formulation, 2017-2032 (USD M

Companies Mentioned

  • Aurora Pharmaceutical, Inc.
  • Biogenesis Bago
  • Biovac Ltd.
  • Boehringer Ingelheim GmbH
  • Ceva Santé Animale
  • Chanelle Pharma
  • China Animal Husbandary
  • Dechra Pharmaceuticals PLC
  • ECO - Animal Health Ltd.
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Intas Animal Health
  • Laboratorio Drag Pharma Chile Invetec S.A.
  • Merck Animal Health
  • Neogen Corporation
  • Norbrook Laboratories Limited
  • Phibro Animal Health
  • Teknofarma S.r.l.
  • Vetoquinol Group
  • Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
  • Virbac S.A.
  • Zendal group
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.08 Billion
Forecasted Market Value ( USD ) by 2032 $ 1.56 Billion
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Equine Pharmaceuticals & Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Equine Pharmaceuticals & Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
Equine Healthcare Market - Global Forecast 2026-2032 - Product Image

Equine Healthcare Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Veterinary Therapeutics Market - Global Forecast 2026-2032 - Product Image

Veterinary Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Equine Healthcare - Global Strategic Business Report - Product Image

Equine Healthcare - Global Strategic Business Report

  • Report
  • 501 Pages
  • Global
From
Equine Supplement Products Market - Global Strategic Business Report - Product Image

Equine Supplement Products Market - Global Strategic Business Report

  • Report
  • 389 Pages
  • Global
From

About the Equine Drug Market

The Equine Drug market is a subset of the Animal Pharmaceuticals industry, focusing on the development and sale of drugs and treatments for horses. These drugs are used to treat a variety of conditions, including respiratory and gastrointestinal diseases, as well as injuries and infections. Equine drugs are also used to improve performance and reduce the risk of injury in horses used for racing and other competitive activities. The Equine Drug market is highly competitive, with a wide range of products available from both large and small companies. Many of these companies specialize in specific areas, such as pain relief, nutrition, and reproduction. In addition, some companies focus on developing new drugs and treatments for horses, while others focus on marketing existing products. Some of the major companies in the Equine Drug market include Merck Animal Health, Boehringer Ingelheim Animal Health, Zoetis, Elanco, and Bayer Animal Health. These companies offer a wide range of products, from vaccines and antibiotics to nutritional supplements and pain relief medications. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.